Please assess the completion status of the following clinical trial:

Trial Title: Study of Bipolar Disorders and Retinal Electrophysiological Markers

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria :~1. Patients:~   * been diagnosed with BD according to the Diagnostic and Statistical Manual of Mental Disorders - 4th edition (DSM-IV) diagnostic criteria using the Mini International Neuropsychiatric Interview (MINI)~  * currently euthymic for at least 3 months prior to the study, as defined by a score below 10 on the Montgomery-Asberg Depression Rating Scale (MADRS) which assesses depression and by a score below 8 on the Young Mania Rating Scale (YMRS) which assesses mania~  * age 18 or more~2. Healthy volunteers:~   * not suffer from a personal psychiatric pathology verified with the MINI~  * age 18 or more~Exclusion criteria for all participants (patients and healthy volunteers):~* suffer from psychiatric pathology or substance use disorders according to DSM-IV criteria measured with the MINI, excluding BD for the patient group~* suffer from neurological or retinal pathology~* having a shift work or a get-lag in the last 15 days~* criteria incompatible with the use of the virtual reality headset (Retinaute®,BioSerenity) like having an allergy to one of the components of the textile~* persons treated by sismotherapy during the past year~* persons with an uncorrected visual impairment or disabling hearing impairment that does not allow neuropsychological tests to be performed~* subjects with an intellectual disability making it difficult to participate in the study or to understand and follow informations provided to them~* adults legally protected~* pregnant or breastfeeding women~* subjects already participating in another interventional trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- patients with bipolar disorder (BD) (Type: EXPERIMENTAL): Electrophysiological recordings with ERG and EEG will be performed with a virtual reality headset after a standardized clinical evaluation (first visit).~Then, an actigraphic monitoring of 21 consecutive days will be carried out. At the end of this period a neuropsychological evaluation will be performed during a second visit.~Between day 23 and day 28 (after the second visit), patients will be offered to assess the retinal structure and microvascularization using Spectral Domain Optical Coherence Tomography (SD-OCT) and OCT-Angiography (OCT-A).
- healthy volunteers (Type: ACTIVE_COMPARATOR): Electrophysiological recordings with ERG and EEG will be performed with a virtual reality headset after a standardized clinical evaluation (first visit).~Then, an actigraphic monitoring of 21 consecutive days will be carried out. At the end of this period a neuropsychological evaluation will be performed during a second visit.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: safety issues